Cargando…
Modeling Alzheimer’s disease with iPSC-derived brain cells
Alzheimer’s disease is a devastating neurodegenerative disorder with no cure. Countless promising therapeutics have shown efficacy in rodent Alzheimer’s disease models yet failed to benefit human patients. While hope remains that earlier intervention with existing therapeutics will improve outcomes,...
Autores principales: | Penney, Jay, Ralvenius, William T., Tsai, Li-Huei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906186/ https://www.ncbi.nlm.nih.gov/pubmed/31391546 http://dx.doi.org/10.1038/s41380-019-0468-3 |
Ejemplares similares
-
Aberrant iPSC-derived human astrocytes in Alzheimer's disease
por: Jones, V C, et al.
Publicado: (2017) -
REST and Neural Gene Network Dysregulation in iPSC Models of Alzheimer’s Disease
por: Meyer, Katharina, et al.
Publicado: (2019) -
Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer’s disease
por: Flannagan, Kaitlin, et al.
Publicado: (2023) -
Limitations of the human iPSC-derived neuron model for early-onset Alzheimer’s disease
por: Valdes, Phoebe, et al.
Publicado: (2023) -
Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
por: Wu, Ying-Chieh, et al.
Publicado: (2021)